
http://www.nationalmssociety.org/clinup_prefilled.asp
December, 2003
The National Multiple Sclerosis Society
The FDA has approved a new delivery system for interferon beta-1b (Betaseron®),
called a Pre-Filled Diluent Syringe. The new system, which reduces the
number of steps involved in reconstituting the medication, includes a syringe
that is pre-filled with the diluent (mixing solution). Previously, the
diluent was stored in a vial and had to be drawn up into the syringe in
order to be mixed with the Betaseron. There have been no changes to the
formulation—the medication is exactly the same—so that it remains non-acidic
and able to be stored at room temperature. The new delivery system will
be available to patients toward the end of January.
Copyright © 2003, The National Multiple Sclerosis Society